tradingkey.logo

Cencora up on raising 2025 profit forecast

ReutersMay 7, 2025 2:15 PM

Shares of drug distributor Cencora COR.N rise 5.7% to $307.50

Co raises annual adj.profit forecast on strong demand for costly specialty medicines and weight-loss drugs

Expects 2025 adj.profit to be between $15.70 and $15.95 per share, up from its previous expectation of $15.30 to $15.60 per share

Q2 revenue at its U.S. healthcare business came in at $68.3 billion, up 11.4% from a year earlier

Reports Q2 adj.profit of $4.42 per share, beating analysts' estimates of $4.11 per share, as per data compiled by LSEG

"The fact that COR has now increased guidance 4x so far in FY25 (this is only the second fiscal quarter report) shows underlying confidence in the business as well"- brokerage Leerink Partners

Including session moves, stock up 36.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI